Trial Profile
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma multiforme
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Jan 2006
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Erlotinib (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 31 Jan 2006 New trial record.